Cardiac Protection in HER2-Targeted Treatment: How Should We Measure New Strategies?.

Cardiac Protection in HER2-Targeted Treatment: How Should We Measure New Strategies?. - 2016


English

2374-2437


*Breast Neoplasms
*Receptor, ErbB-2
Humans


MedStar Heart & Vascular Institute
Washington Cancer Institute


Journal Article

Powered by Koha